Margaret Atwood’s The Testaments and the Oscar-winning film One Battle After Another are grim parables of today. But they are not without hope
As Margaret Atwood has said, all dystopian fiction is “re…
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Gilead
since
auto-detected in 12 stories
3 days ago
6 days ago
The Testaments review – brace yourself for a bloody sequel to The Handmaid’s Tale ⊖⊖
Don’t be fooled by the lighter tone of Margaret Atwood’s follow-on. June’s daughter is now grown up in Gilead, where daily horrors are still in full swing – and Aunt Lydia is back
I had to give up on …
11 days ago
The Testaments to Big Mistakes: the seven best shows to stream this week ⊕
Chase Infiniti stars in Margaret Atwood’s gripping sequel to the Handmaid’s Tale, plus Dan Levy’s irresistibly goofy new sitcom will thrill Schitt’s Creek fans
This expansion of the Handmaid’s Tale un…
21 days ago
Gilead nears up to $2bn deal for autoimmune biotech Ouro Medicines ⊕
California-based drugmaker takes advantage of surging share price to strike takeovers after a quiet couple of years
50 days ago
Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion ⊖⊖
Gilead Sciences said on Monday it will buy cancer therapy partner Arcellx for an implied equity value of $7.8 billion.
5 months ago
Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings ⊕
found
Eli Lilly, Merck, Gilead, Bristol Myers Squibb and AbbVie, among other pharmaceutical companies, are slated to report third-quarter earnings this week.
9 months ago
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option ○
The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts.
‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers ○
As regulator prepares to approve lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’
A drug with the potential to “end the…
10 months ago
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO ○
found
Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, Medicare patients.